Take a look at the top news stories of the week, including a focus on antimicrobial resistance and industry, and new influenza research.
Browsing: Viral > Zika
Learn more about the top news stories of the week in our round-up, including the latest research on influenza, and new findings in MRSA infection.
Interferons are critical for a mother’s immune response during Zika infection, but could have detrimental impacts on placental and fetal development, according to new research.
The exact mechanism(s) linking fetal Zika infection and congenital microcephaly remains unclear, however, an international team of researchers have now identified a possible role for unfolded protein responses in this process.
Researchers from Yale University have suggested that the immune response may be responsible for neurological complications in Zika infection, as opposed to the virus itself.
Blood samples from US athletes and staff who travelled to Rio de Janeiro, Brazil, for the 2016 Summer Games were not infected with Zika virus but tested positive for other viral infections, including West Nile Virus, dengue and chikungunya.
A new DNA-based Zika vaccine, GLS-5700, has been reported as safe and immunogenic in Phase I trial, according to new research.
Researchers have discovered that antibodies taken from dengue virus infected individuals are effective in treating Zika infection – a closely related flavivirus – in rodents.
Research in mice and cell lines has demonstrated the potential of Zika virus to target and kill glioblastoma stem cells, suggesting a possible new treatment for this brain cancer.